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Background: The emergence of avian influenza A/H5N1 in 2003 as well as the pandemic influenza A (H1N1)
pdm09 highlighted the need to establish influenza sentinel surveillance in Togo. The Ministry of Health decided to
introduce Influenza to the list of diseases with epidemic potential. By April 2010, Togo was actively involved in
influenza surveillance. This study aims to describe the implementation of ILI surveillance and results obtained from
April 2010 to December 2012.
Methods: Two sites were selected based on their accessibility and affordability to patients, their adequate
specimen storage capacity and transportation system. Patients with ILI presenting at sentinel sites were enrolled by
trained medical staff based on the World Health Organization (WHO) case definitions. Oropharyngeal and
nasopharyngeal samples were collected and they were tested at the National Influenza Reference Laboratory using
a U.S. Centers for Disease Control and Prevention (CDC) validated real time RT-PCR protocol. Laboratory results and
epidemiological data were reported weekly and shared with all sentinel sites, Ministry of Health, Division of
Epidemiology, WHO and CDC/NAMRU-3.
Results: From April 2010 to December 2012, a total of 955 samples were collected with 52% of the study
population aged between 0 and 4 years. Of the 955 samples, 236 (24.7%) tested positive for influenza viruses; with
136 (14.2%) positive for influenza A and 100 (10.5%) positive for influenza B. The highest influenza positive
percentage (30%) was observed in 5–14 years old and patients aged 0–4 and >60 years had the lowest percentage
(20%). Clinical symptoms such as cough and rhinorrhea were associated more with ILI patients who were positive
for influenza type A than influenza type B. Influenza viruses circulated throughout the year with the positivity rate
peaking around the months of January, May and again in October; corresponding respectively to the dry-dusty
harmattan season and the long and then the short raining season. The pandemic A (H1N1) pdm09 was the
predominantly circulating strain in 2010 while influenza B was the predominantly circulating strain in 2011. The
seasonal A/H3N2 was observed throughout 2012 year.
Conclusions: This study provides information on influenza epidemiology in the capital city of Togo.
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Influenza-like-illnesses (ILI) is a significant source of
morbidity and mortality worldwide [1]. The World Health
Organization (WHO) estimates that globally influenza
accounts for between 3 and 5 million severe cases and
250.000 to 500.000 deaths annually, with most deaths oc-
curring among elderly populations [2].
In temperate regions, ILI is reported throughout the
year with a marked increase in cases recorded during
winter periods [3]. However, in tropical and subtropical
regions where viral transmission occurs throughout the
year, the data on the burden of influenza-like-illness are
limited. Nevertheless there is some evidence of a slight
increase in cases during the rainy season [4,5].
The emergence of new highly pathogenic influenza A/
H5N1 viruses in 2003 [6], their wide circulation in wild and
domestic birds and its association with human infections
which involves high mortality, has raised global concern
about the risk of another influenza pandemic. The emer-
gence of novel human pandemic influenza A (H1N1) in
April 2009 [7,8] and its rapid worldwide spread has moti-
vated the monitoring of influenza and has enhanced pre-
paredness to counter a possible emerging pandemic. In
the African Region, countries in collaboration with inter-
national partners (e.g. WHO, CDC, NAMRU-3, etc.) put
efforts together to establish influenza surveillance capacities
as part of the broader strategy for Integrated Disease
Surveillance and Response (IDSR) [9,10]. While most
countries in Asia, North America and Europe have well-
established influenza surveillance, few such systems
have been established in sub-Saharan Africa [5,11].
Influenza surveillance helps in understanding the
epidemiology and impact of the disease; therefore pro-
viding information about seasonality and the groups at
high risk of influenza infection. Furthermore, the identi-
fication and characterization of circulating viruses will
help to provide influenza isolates for monitoring
changes in viral antigens and the development of vac-
cines. Thus influenza surveillance provides data for pan-
demic influenza monitoring and planning as well as for
decision-making [12-14].
In Togo, the first suspected cases of human avian in-
fluenza A/H5N1 were reported between 2007 and 2008
in the Maritime Region, a few kilometers from the cap-
ital city Lomé, which has a population of more than 2
millions. Between April and December 2009, cases of ILI
were observed and were suspected to be pandemic influ-
enza given the emergence of the novel human pandemic
influenza A (H1N1) pdm09. With no ongoing influenza
surveillance, our country was not yet ready to confirm
and effectively monitor the severity of the disease. The
lack of molecular laboratory technology to detect influ-
enza viruses significantly reduced our ability to manage
and control the pandemic. Therefore, the Ministry ofHealth (MoH) in collaboration with the Institut National
d’Hygiène (INH) decided to add influenza to the list of
diseases with epidemic potential to be monitored and re-
ported through the IDSR Program. By April 2010, Togo
was actively involved in ILI surveillance with the support
of United State Government through the Centers for
Disease Control (CDC) and the Naval Medical Research
Unit-3 (NAMRU-3).
This study aims to describe the implementation of ILI




The ILI surveillance system constitutes a collaborative
partnership between several Togolese institutions within
the Ministry of Health (MoH). The departments involved
in this surveillance are the Division of Epidemiology, the
National Influenza Reference Laboratory (NIL) hosted by
the Institut National d’Hygiène (INH), and the sentinel
sites located at the Hôpital de Bè and Military Health
Services in the capital city Lomé (Figure 1). A protocol for
influenza surveillance was written with the technical sup-
port of CDC and NAMRU-3 experts.
Sentinel sites selection
The ILI sentinel surveillance sites were selected based
on their accessibility and affordability to patients with
low socioeconomic status, the qualifications of medical
staff, adequate specimen storage capacity, and an estab-
lished transportation system to the National Influenza
Reference Laboratory (NIL).
The first site was Hôpital de Bè, established in April
2010 and located in District N°3. This site was chosen
for its geographical location in an area of high popula-
tion density and high consultation rate. This hospital
hosts a pediatric unit and a general medicine ward. The
second site established in December 2011, is under the
management of the Military Health Services and located
in District N°5; its selection was based on the essential
role of the Armed forces in case of a pandemic and their
ability to serve both military and civilian populations.
This military site is composed of three units and is
attended by military personnel, their families as well as
civilians.
The two sentinel sites are located in the capital city of
Togo where approximately 20% of the country’s popula-
tion lives. Lomé has two rainy seasons and two dry sea-
sons: the long rainy season (April to June) and the short
rainy season (mid-September to October). The long dry
season extends from December through March, while the
short dry season lasts for two months (July to August).
Lomé is a coastal city that borders the Atlantic Ocean to
the south, Ghana to the west, Benin to the east (Figure 1)
Figure 1 Lomé commune region localization and institutions involved in the ILI sentinel Surveillance, Togo, April 2010-December
2012. Lomé commune region is one of the six health region in Togo. Suspected cases of avian influenza A/H5N1 in poultry farms (yellow circles):
In 2007 at Sigbéhoué (District des Lacs), Adétikope (District du Golfe) and Agodekê (District de Zio). In 2008 at Agbata (District des Lacs). All
theses foci were located at few kilometers from the capital city, Lomé.
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change of goods and movements of population.
Case definition and study population
The WHO case definition [15] that was used, defined ILI as
“any person with a sudden onset of fever (≥38°C) and
cough or sore throat accompanied or not by general symp-
toms such as myalgia, prostration, headache or malaise”.
This definition was used during 2010–2011 period. In
2012, the definition was changed to “any person with a sud-
den onset of fever (≥38°C) or history of fever and cough or
sore throat accompanied or not by general symptoms such
as myalgia, prostration, headache or malaise”.
At both sentinel sites, from Monday to Friday physicians
enrolled the first two outpatients who met the case defin-
ition and samples were collected during consultation.
The study population included every outpatient, be-
tween April 2010 to December 2012, presenting at any
of the sentinel sites and meeting the ILI case definitionsregardless of age or sex and who consented to partici-
pate in the surveillance. This population represents a
wide cross-section of ethnic and socioeconomic groups.
Sample collection
Samples collected were nasopharyngeal and oropharyn-
geal swabs and were placed in the same tube containing a
viral transport medium (VTM). They were stored between
2 to 8°C at the bacteriology laboratory of the sentinel site
prior to delivery to the NIL within 48 hours. Before sam-
ples were transported, laboratory personnel at the sentinel
site conducted quality control checks of information on
patients’ case report forms. The NIL provides the sentinel
sites with logistical and material support such as swabs,
viral transportation media, cryovials, cool boxes, and ice
packs. A quota of 20 samples was targeted from each sites
and transported twice a week (Tuesday and Thursday) to
the NIL. Review meetings with all stakeholders were orga-
nized two or three times per year as part of a strategy to
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and areas of concern during these meetings.
Data collection and management
Socio-demographic (age, sex, date of birth, residential
area, travel history) and clinical (date of onset, date of
consultation, previous treatment, vaccination status,
co-morbidities) data were collected from all patients
using a case report form (CRF) during consultation. Epi-
demiological data were stored in a single database with
laboratory data using a single identification number for
each patient. Each week, NIL provided reports on the
distribution of total samples collected, as well as on the
number of confirmed influenza cases to the MoH, to
the sentinel sites, WHO FluNet, CDC, and NAMRU-3.
Laboratory analysis
Samples collected were analyzed at the National Refer-
ence Influenza laboratory at INH. From every sample,
three aliquots were made, two of which were stored at
−80°C for external quality control and further analysis (if
not subtyped) at NAMRU-3 in Cairo, Egypt. The other
one was kept between 2 to 4°C for RNA extraction
followed by influenza virus detection by real time RT-
PCR within 72 hours after sample reception.
RNA extraction and real time RT-PCR
For the testing of influenza viruses, RNA extraction was
performed from 140 μl of naso and/or oro-pharyngeal
cells contained in the VTM by using a QIAmp Viral RNA
Mini Kit (Qiagen) following the manufacturer’s protocol.
For detection and typing, it was run on an ABI 7300 ma-
chine, the real time RT-PCR using the Ambion enzyme
AgPath one-step (Ambion, Applied Biosystems) that amp-
lifies Influenza A and B. The U.S. CDC provided the
protocol used to detect influenza viruses [16]. In order to
determine the quality of the sample, the presence of hu-
man ribo-nucleoprotein (RNP) was assessed for each spe-
cimen tested.
Statistical analysis
Socio-demographic and clinical epidemiological data were
entered into a database created using Epi-Info Software
version 3.5. Data analysis was conducted using SPSS soft-
ware version 16.0 (SPSS Inc., Chicago, IL). Student t-test
was used for comparison of mean age and the Pearson
Chi-square or Fisher exact test to compare laboratory re-
sults by age groups and clinical symptoms.
Ethical considerations
The protocol was approved by the MoH as part of the
monitoring of diseases with epidemic potential and there-
fore did not require ethical review. Verbal consent was ob-
tained from all patients.Results
Characteristics of population
A total of 955 patients were enrolled in this study. Seven
hundred and twenty seven (76%) patients were enrolled
from the Hôpital de Bè and 228 (24%) from the Military
Health Service site (Table 1). There was no significant
difference in the proportion of females compared to
males enrolled in this study (49.9% vs. 50.1%; p = 0.37),
and the gender distribution at the two sites was similar.
Most of patients (65%) were under 15 years of age, while
less than 6% were 45 years or older. Patients who pre-
sented at the Hôpital de Bè were significantly older
(mean age = 17.1 years) compared to those who were
seen at the Military Health Service (mean age = 10.6 years
with 71% of patients aged less than 5 years) (p = 0.0001).
Approximately 2% of the patients reported having re-
ceived influenza vaccination within the last year.
Laboratory results
Of the samples collected for ILI surveillance, 236 (24.7%)
tested positive for influenza viruses. Of these, 136 (14.2%)
tested positive for influenza A virus and 100 (10.5%) for
influenza B virus (Table 2). The proportion of influenza
positive cases ranged from 32% in 2010 to 22.5% in 2012.
Type and subtype varied by year, with influenza A being
predominant in 2010 and 2012, and influenza B predom-
inant in 2011. Of the influenza A subtypes, pandemic A
(H1N1) pdm09 was predominant in 2010 while seasonal
A/H3N2 was predominant in 2012 (Table 2). The propor-
tion of influenza positive cases varied between different
age groups with a higher proportion of influenza A de-
tected in the 15–29 year-old group (20%) than other age
groups (p = 0.01; Table 3). Significantly, the pandemic in-
fluenza A (H1N1) pdm09 was more often detected in pa-
tients aged 5–14 (p = 0.003) and 15–29 (p = 0.03) years
than in other age groups. Seasonal A/H3N2 was predom-
inant in patients aged 30–44 years (15%; p = 0.0003) and
was the only influenza A subtype detected among patients
who were 60 years or older.
Temporal distribution
ILI was observed throughout every year with irregular
peak activity occurring twice annually during the months
of; May and November in 2010; May and October in
2011; April/August, October in 2012 (Figure 2). However,
the number of patients/samples enrolled was not consist-
ent. Influenza A virus was detected predominantly in 2010
and correlated with the ILI peak. The first cases of pan-
demic influenza A (H1N1) pdm09 were only confirmed in
May. During the ILI peak, the influenza positivity rate was
26% in May and 30% in November with the pandemic in-
fluenza strain, the most subtype detected. The pandemic
virus remained predominant between October 2010 and
April 2011 (Figure 2). During the ILI peaks in 2011, the
Table 1 Characteristics of ILI patients enrolled into the influenza sentinel surveillance system, Togo,
April 2010-December 2012
Hôpital





Number of subjects enrolled 228 955 727
Sex
Female 369 (50,8) 108 (47,4) 477 (49,9)
Male 358 (49,2) 120 (52,6) 478 (50,1)
Age
Mean ± Std (yrs) 10,6 ± 13,2 15,7 ± 16,5 17,1±17,05
Median (range in yrs) 3 [1mo-58] 6 [1mo-90] 8 [1mo-90]
0-4 330 (45,3) 162 (71,0) 492 (51,5)
5-14 114 (15,7) 19 (8,3) 133 (13,9)
15-29 122 (16,8) 25 (10,9) 147 (15,4)
30-44 114 (15,7) 19 (8,3) 133 (13,9)
45-59 37 (5,1) 3 (1,3) 40 (4,2)
≥60 10 (1,4) 0 (0,0) 10 (1,0)
Vaccination history (Self reported) 3 (1,3) 17 (1,8) 14 (1,9)
Std = Standard mo =month yrs = years.
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predominance of influenza B virus activity in May repre-
senting 93% of all virus detected (28/30). The second peak
was correlated to the seasonal influenza A/H3N2 activity
in October with 80% of viruses detected (8/10). From
October 2011, there was a co-circulation of influenza type
A and type B with low activity of pandemic strain until
September 2012 while the seasonal influenza A/H3N2
was detected throughout the year 2012.
Clinical manifestations
Fever (85%), cough (87%), and rhinorrhea (76%) were the
major symptoms for all age groups although sore throat
(38%) and headaches (14%) were also recorded (Table 4).
ILI patients who tested positive for influenza were more
likely to present with cough (p = 0.004) and headaches
(p = 0.03) but were less likely to present with difficulty
breathing (p = 0.02) compared to those who tested nega-
tive for the influenza virus. Among symptoms, only cough
was more common in patients testing positive for influ-
enza A than those who tested positive for influenza BTable 2 Distribution of number of samples collected and influ
April 2010-December 2012




April to December 2010 87 28 (32.2) 3 (3.4)
2011 335 88 (26.3) 49 (14.6)
2012 533 120 (22.5) 48 (9.0)
Total 955 236 (24.7) 100 (10.5)(p = 0.003). Rhinorrhea was more common in patients
with seasonal A/H3N2 than in those with pandemic influ-
enza A (H1N1) pdm09 (p = 0.0004).
Discussion
Due to the lack of ILI surveillance in Togo, there was no
information about the epidemiology of ILI or influenza
viruses until 2010. The first samples collected were proc-
essed in May 2010 and the presence of pandemic influ-
enza A(H1N1) pdm09 virus was confirmed in Togo one
year after the novel pandemic influenza occurred in
Mexico (April 2009). This is the first report that de-
scribes the epidemiology of influenza in Togo using data
from the ILI sentinel surveillance system. During
the two and half year period of ILI sentinel surveillance,
influenza viruses were detected in 236 (25%) of 955
samples. The average percentage positive in this study
was higher than the positivity rate observed in 15 other
African countries between 2006 and 2010 [17]. However,
during the same timeframe, other countries in the
temperate climate region: Madagascar (40%), Moroccoenza positivity rate by year, Togo,









25 (28.7) 3 (3.4) 21 (24.1) 1 (1.1)
39 (11.6) 17 (5.1) 20 (5.9) 2 (0.6)
72 (13.5) 51 (9.5) 21 (3.9) 0 (0.0)
136 (14.2) 71(7.4) 62 (6.5) 3 (0.3)
Table 3 Distribution of influenza viruses confirmed and ILI patients by age, Togo, April 2010-December 2012
Subtypes of influenza A














0-4 492 392 (79.7) 100 (20.3) 48 (9.7) 52 (10.6) 29 (5.9) 21 (4.3) 2 (0.4)
5-14 133 92 (69.2) 41 (30.8) 20 (15.0) 21 (15.8) 5 (3.7) 16 (12.0) 0 (0.0)
15-29 147 107 (72.8) 40 (27.2) 10 (6.8) 30 (20.4) 11 (7.5) 19 (12.9) 0 (0.0)
30-44 133 92 (69.2) 41(30.8) 17 (12.8) 24 (18.0) 20 (15.0) 3 (2.2) 1 (0.7)
45-59 40 28 (70.0) 12 (30.0) 5 (12.5) 7 (17.5) 4 (10.0) 3 (7.5) 0 (0.0)
≥60 10 8 (80.0) 2 (20.0) 0 (0.0) 2 (20.0) 2 (20.0) 0 (0.0) 0 (0.0)
Total 955 719 (75.3) 236 (24.7) 100 (10.5) 136 (14.2) 71 (7.4) 62 (6.5) 03 (0.3)
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rate as well as Peru (35%; 2006–2008) [18].
There are several reasons to explain the difference in
the percentage positive observed between countries in-
cluding the temporal distribution of these viruses, the
sample collection method, the number of samples col-
lected and the geographical distribution of sentinel sites.
Most of our data includes post pandemic influenza A
(H1N1) pdm09; this is a different picture compared to
other African countries (2006–2010) and to the South
American region. The sample collection method was dif-
ferent from one country to another. In our study, we
used two swabs (one oro-pharyngeal and one naso-
pharyngeal) for each enrolled patient and put both swabs










































































































Figure 2 Monthly distribution of number of samples collected and in
influenza positivity rate was 26% in May and 30% in October and corralate
2010. In 2011 year, the influenza B became predominant and representing
peak of ILI was observed and corralated with the seasonal influenza A/H3N
type A and type B.and enhancing RT-PCR detection while in some other
countries samples were collected either with naso-
pharyngeal [19] or oro-pharyngeal swab only [18,20]. In
addition, the number of samples tested in most of the
other countries was quite high compared to our sample
numbers and they were collected from many sites ran-
ging from only 3 to as many as 22. We only used two
sentinel sites as our catchment area. The influenza posi-
tivity rate varied by year with the highest rate obtained
in 2010. Since the number of samples collected during
this year was very low (87 samples) than the two subse-
quent years, the rate could be influenced. Nevertheless,
our percentage positive was similar to that of Ghana and
Rwanda in Africa [17] and that of Taiwan [21], but at






























































































Influenza B Number of  samples collected
fluenza viruses confirmed, Togo, April 2010-December 2012. The
d with the presence of the pandemic influenza A (H1N1) pdm09 in
93% of all viruses detected in May. During the same year, a second
2 in October. From this month, there was a co-circulation of influenza



















Fever 813 (85.1) 614 (85.3) 199 (84.3) 88 (88.0) 111 (81.6) 59 (83.1) 49 (790.0) 3 (100)
Cough 834 (87.3) 615 (85.5) 219 (92.8) 87 (87.0) 132 (97.0) 68 (95.8) 61 (98.4) 3 (100)
rhinorrhea 725 (75.9) 541 (75.2) 184 (78.0) 80 (80.0) 104 (76.4) 63 (88.7) 39 (62.9) 2 (66.7)
Sore throat 367 (38.4) 265 (36.8) 102 (43.2) 47 (47.0) 55 (40.4) 24 (33.8) 28 (45.2) 3 (100)
Headache 141 (14.8) 96 (13.3) 45 (19.1) 15 (15.0) 30 (22.0) 18 (25.3) 12 (19.3) 0 (0.0)
Difficulty of breath 175 (18.3) 144 (20.8) 31 (13.1) 14 (14.0) 17 (12.5) 11 (15.5) 6 (9.8) 0 (0.0)
Total 955 719 (75.3) 236 (24.7) 100 (10.5) 136 (14.2) 71 (7.4) 62 (6.5) 3 (0.3)
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fluenza A (H1N1) pdm 09 in our study; this observation
was similar to that of other countries in West Africa [17].
However, in 2010, the situation was different in other sub-
regions with predominance of influenza B in Central/South
and North Africa [17,22] and seasonal influenza A/H3N2
in East Africa [17]. This difference could be explained by
the fact that circulation of pandemic influenza A (H1N1)
pdm09 was delayed in West Africa and occurred one year
after it was predominantly circulating in other African sub-
regions [17,23]. While two years is not sufficient time for
an adequate description of the seasonality of influenza virus
transmission, we did observe trends in the Lomé commune
region. The influenza B virus showed a peak activity during
the rainy seasons (May and October) and the pandemic in-
fluenza A (H1N1) pdm09 was more frequent during the
long dry season while the seasonal A/H3N2 was detected
across both seasons. Although the seasonality of influenza
viruses in African countries is not yet clear, we observed
that our trends were similar with the influenza peaks, which
have often been associated with the rainy season activity in
other tropical countries [24-26].
In our study, Influenza cases were highest (30%) in the
5–14 year age group but also high among other age
groups, with lowest percent positive (20.3%) among 0–4
and > 60 years (20.0%). This distribution is consistent with
the observation in the study conducted in 15 countries of
Africa during 2006 to 2010 and in Peru [17,18,20] in
which young children and adults were shown to have the
highest influenza viral disease. Contrary to our study, a
study from Venezuela [27] showed higher detection rates
in 0–4 year olds. The percentage positive of influenza A
was significantly higher in ILI patients in the 15–29 age
groups. Therefore, we found that pandemic influenza A
(H1N1) pdm09 was detected significantly among 5–29
years old. This finding is consistent with other studies
in the African region [17,22,28] that have found that
pandemic influenza A (H1N1) pdm09 is most commonly
identified in school-age children and young adults. While
pandemic influenza A (H1N1) pdm09 appeared moreoften in older children, seasonal influenza A/H3N2 ap-
peared more likely to infect adults in the 30–44 year-age
category. Our finding was similar to the observation from
a study conducted in Peru [18], where the author found
that the seasonal influenza A/H3N2 virus was detected
with adults of 45 to 59 years. In conclusion, our results are
consistent with studies from Africa and South American re-
gions which observed that seasonal influenza A/H3N2
affected a wide range of age groups with predominantly 30
to 60 years old while the pandemic influenza A (H1N1)
pdm09 and influenza B virus infections occurred more fre-
quently among older children and young adults.
We observed that clinical symptoms were associated
with influenza viruses. The influenza type A was more
frequently detected than type B in patients presenting
with cough and rhinorrhea. This result is consistent with
the observation of a study from Venezuela [27]. In con-
trast with this study were pandemic influenza A (H1N1)
pdm09 was associated with ILI patients with cough, our
study showed that ILI patients with rhinorrhea were as-
sociated with seasonal A/H3N2.
Our study had some limitations. Our data were col-
lected only from 2 sites in an urban area in the capital
city of Togo and could not be generalized to the popula-
tion. The percent influenza positivity and age distribu-
tion of positive cases were influenced by the low number
of samples collected which may be attributable to the
non availability of a physician to collect nasal and
orpharyngeal swabs. The low number of samples may
have also contributed to the high positivity rate. In
addition, this low proportion may not be representative
to better describe the distribution of influenza cases in
the age groups. Physician time limitations were due to
the time consumption and their workload (number of
patients viewed in consultation at the outpatients’ de-
partment). Children were over-represented in this study
thus introducing a bias, as the number of adults was not
comparable to children under 5 years old. Some possible
reasons to explain this bias include the fact that the
Military Health Service has three units but only the
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a site in December 2011. Because this unit is a pediatric
health center, the high number of children enrolled from
this site can account for the observed figures. At the
Hôpital de Bè site, we observed that many patients,
mostly adults were not enrolled as ILI patients due to
the lack of recorded fever (≥38°C), suggesting that we
should be considering history of fever as one of the en-
rollment criteria for ILI. This study focused exclusively
on outpatients thus limiting our ability to examine the
severity of the influenza viruses in hospitalized cases.
Since our influenza surveillance system had challenges
in collecting samples of severe acute respiratory infec-
tion (SARI) and the lack of data on hospitalizations with
patient follow-up we excluded discussions on SARI from
this study. To improve our influenza surveillance system,
it will be necessary to expand the system in other re-
gions by including SARI surveillance for severe disease
to give a complete picture of influenza burden and epi-
demiology in our country.
Conclusions
These data provided information on the epidemiology of
influenza in the Lomé commune region in the capital
city of Togo. Some efforts are needed to allow better un-
derstanding of influenza burden and epidemiology by
expanding sentinel sites in other regions and including
SARI surveillance. Future studies will also be focused on
identifying the etiologic agents for the 75% of ILI cases
that were negative for influenza viruses. Retrospective
analyses of these stored samples will be necessary to
identify other respiratory viruses circulating, including
respiratory syncytial virus (RSV), coronaviruses, Human
Metapneumovirus (HMPV) and rhinoviruses.
Abbreviations
ILI: Influenza-like illness; WHO: World Health Organization; ISDR: Integrated
Disease Surveillance and Response; INH: Institut National d’Hygiène;
NIL: National Influenza Laboratory; CDC: Centers for Disease Control and
Prevention; NAMRU-3: Naval Medical Research Unit 3.
Competing interests
The authors have declared that no competing interests exist.
Authors’ contributions
IM contributed to the study design, statistical analyses of data and wrote the
paper. KB and EDL contributed to the study design, interpreted analysis and
review the manuscript. AWH and TAT contributed in the study design and
review the manuscript. TNN, GND, WT and PJK provide technical advice for
study protocol, methodology, revised critically the manuscript for important
scientific content and have given final approval for the version to be
published. ZI and KK were involved in literature review and revising the
manuscript. ABK contributed to the facilitation of the project, participated in
its design, coordination and review the paper. All authors read and approved
the final manuscript.
Acknowledgements
We would like to thank all sentinel staff at the Hôpital de Bè and the Military
Health services for their essential role in the ILI sentinel surveillance. We are
grateful to the Ministry of Health and the Division of Epidemiology for theirsupport and coordination. We would like also express our sincere thanks to
the team of the National Influenza Reference Laboratory for their efforts in
collecting samples, clinical data and detection by RT-PCR of influenza viruses.
We wish to thank Mr Koffi Akolly, Field Epidemiologist for designing the map
of the Figure 1. The influenza sentinel surveillance was successful established
with the technical and financial support of CDC and NAMRU-3. We are grate-
ful also to CDC reviewers for their precious analyses and revision of this
paper prior it’s submission for publication.
Author details
1National Influenza Reference Laboratory, Institut National d’Hygiène, 26 QAD
Rue Nangbeto, 01 Lomé-Sud, POBOX: 1396, Lome, Togo. 2Division de
l’Epidémiologie, Ministry of Health, Lomé, Togo. 3Influenza Division, U.S.
Centers for Disease Control and Prevention, Atlanta, GA, USA. 4Virology
Department, U.S. Naval Medical Research Unit No 3, Cairo, Egypt. 5McKing
Consulting, Influenza Division, U.S. Centers for Disease Control and
Prevention, Atlanta, GA, USA.
Received: 25 January 2014 Accepted: 16 September 2014
Published: 20 September 2014References
1. WHO: The global burden of disease: 2004 update. 2004 [http://whqlibdoc.
who.int/publications/2008/9789241563710_eng.pdf]
2. WHO: Influenza Fact Sheet Available. 2007 [http://www.who.int/mediacentre/
factsheets/fs211/en. Accessed 2007 Oct 30].
3. Simonsen L: The global impact of influenza on morbidity and mortality.
Vaccine 1999, 17:S3–S10.
4. Moura FE, Perdigão AC, Siqueira MM: Seasonality of influenza in the
tropics: a distinct pattern in northeastern Brazil. Am J Trop Med Hyg 2009,
81(1):180–183. PMid: 19556586.
5. Shek LP, Lee BW: Epidemiology and seasonality of respiratory tract virus
infections in the tropics. Paediatr Respir Rev 2003, 4:105–111.




7. WHO: Pandemic (H1N1). 2009 [http://www.who.int/csr/don/2010_08_06/en/
index.html (Accessed 15 October 2012)].
8. Archer BN, Cohen C, Naidoo D, Thomas J, Makunga C: Interim Report on
Pandemic H1N1 Influenza Virus Infections in South Africa, April to
October 2009: Epidemiology and Factors Associated with Fatal Cases.
Euro Surveill 2009, 2009(14):11–15.
9. Robert FB, Abdulsalami N, Mark A, Kariuki N, John V: Preparedness for
highly pathogenic avian influenza pandemic in Africa. Emerg Infect Dis
2007, 13:1453–8.
10. WHO Regional Office for Africa: Integrated disease surveillance in the
African region: a regional strategy for communicable diseases 1999–2003;
2003 [http://www.afro.who.int/csr/ids/publications/ids.pdf]
11. Katz MA, Shoub BD, Heraud JM, Breiman RF: Influenza in Africa:
Uncovering the Epidemiology. J Infect Dis 2012, 206(Suppl 1):S1–4.
12. Hilleman MR: Realities and enigmas of human viral influenza: pathogenesis,
epidemiology and control. Vaccine 2002, 20(25–26):3068–3087.
13. WHO: Recommended composition of influenza virus vaccines for use in
the, northern hemisphere influenza season. Wkly Epidemiol Rec 2011 2011,
10(86):81–92. [http://www.who.int/wer]
14. WHO: Recommended composition of influenza virus vaccines for use in
the 2013 southern hemisphere influenza season. Wkly Epidemiol Rec 2012,
41(87):389–400.
15. WHO: Global Influenza Surveillance Network (GISN). Manual for the laboratory
diagnosis and virological surveillance of influenza: 2011. [http://www.who.
int/influenza/resources/documents/INFSURVMANUAL.pdf]
16. WHO: CDC protocol of real time RT-PCR for detection and characterization
influenza 2009 A (H1N1) pdm virus. April 2009. 2009. [http://www.who.int/csr/
resources/publications/swineflu/CDCRealtimeRTPCR_SwineH1Assay-
2009_20090430.pdf]
17. Radin JM, Katz MA, Stefano T, Nzussouo TN, Richard D, Duque J, Adebayo A,
Adjabeng MJ, Ampofo WK, Ayele W, Bakamutumaho B, Barakat A, Cohen
AL, Cohen C, Dalhatu IT, Coulibaly D, Dueger E, Francisco M, Heraud J-M,
Daddi J, Kabanda A, Kadjo H, Kandeel A, Shamamba SKB, Kasolo F,
Maman et al. BMC Public Health 2014, 14:981 Page 9 of 9
http://www.biomedcentral.com/1471-2458/14/981Kronmann KC, Liwewe MLM, Lutwama JJ: Influenza Surveillance in 15
countries in Africa, 2006–2010. J Infect Dis 2012, 206(Suppl):S14–21.
18. Laguna-Torres VA, Gomez J, Ocana V, Aguilar P, Saldarriaga T, Chavez E, Perez J,
Zamalloa H, Forshey B, Paz I, Gomez E, Roel O, Chauca G, Ortiz E, Villaran M,
Vilcarromero S, Rocha C, Chincha O, Jimenez G, Villanueva M, Pozo E, Aspajo J,
Kochel T: Influenza-like illness sentinel surveillance in Peru. PLoS One 2009,
4(7):e6118.
19. Clayton OO, Njeru R, Kazungu S, Achilla R, Bulimo W, Welch SR, Cane PA,
Gunson RN, Hammitt LL, Scott AGJ, Berkley JA, Nokes DJ: Influenza
Surveillance Among Children With Pneumonia Admitted to a District
Hospital in Coastal Kenya, 2007–2010. J Infect Dis 2012, 206(S1):61–7.
20. Workenesh A, Gelila D, Woubayehu K, Zemelak E, Afework A, Amare B, Cox
CM, Daddi J: Challenges of Establishing Routine Influenza Sentinel
Surveillance in Ethiopia, 2008–2010. J Infect Dis 2012, 206(S1):S41–5.
21. Chuang J-H, Huang AS, Huang W-T, Liu M-T, Chou J-H, Chang F-Y, Chiu W-T:
Nationwide Surveillance of Influenza during the Pandemic (2009–10) and
Post-Pandemic (2010–11) Periods in Taiwan. Plos one 2012, 7(4):e36120.
22. Tamfum JJM, Nkwembe E, Shamamba SKB, Bankoshi F, Ilunga BK, Katz KA,
Cohen AL, Kabamba J, Wemankoy EO: Sentinel Surveillance for Influenza-like
illness, severe acute respiratory illness and Laboratory-Confirmed influenza
in Kinshasa, Democratic Republic of Congo, 2009–2011. J Infect Dis 2012,
206(Suppl):S36–40.
23. Ndahwouh Talla N, Michalove J, Ousmane MD, Njouom R, Lourdes Monteiro
M, Kadjo H, Manoncourt S, Amankwa J, Koivogui L, Sow S, Elkory MB, Collard
J-M, Dalhatu I, Mbayame NN, Lafond K, Moniz F, Coulibaly D, Kronman KC,
Oyofo BA, AmpofoW K, Boubou T, Bara AO, Jusot J-F, Ekanem E, Diène Sarr F,
Hwang I, Cornelius C, Coker B, Stephen L, Richard D: Delayed 2009 Pandemic
Influenza A Virus Subtype H1N1 Circulation in West Africa, May 2009–April
2010. J Infect Dis 2009, 206(Suppl 1):S106–112.
24. Dosseh A, Ndiaye K, Spiegel A, Sagna M, Mathiot C: Epidemiological and
virological influenza survey in Dakar, Senegal: 1996–1998. Am J Trop Med
Hyg 2000, 62:639–43.
25. Zaman RU, Alamgir AS, Rahman M: Influenza in outpatient ILI case-patients
in national hospital-based surveillance, Bangladesh, 2007–2008. PLoS One
2009, 4:e8452.
26. Alonso WJ, Viboud C, Simonsen L, Hirano EW, Daufenbach LZ, Miller MA:
Seasonality of influenza in Brazil: a traveling wave from the Amazon to
the subtropics. Am J Epidemiol 2007, 165:1434–42.
27. Comach G, Teneza-Mora N, Kochel TJ, Espino C, Sierra G, Camacho DE,
Laguna-Torres VA, Garcia J, Chauca G, Gamero ME, Sovero M, Bordones S,
Villalobos I, Melchor A, Halsey ES: Sentinel Surveillance of Influenza-Like
Illness in Two Hospitals in Maracay, Venezuela: 2006–2010. Plos one 2012,
7(9):e44511.
28. Dalhatu IT, Medina-Marino A, OlsenS J, Hwang I, Gubio AB, Ekanem EE,
Coker EBA, Akpan H, Adedeji A: Influenza Viruses in Nigeria, Results From
the First 17 Months of a National Influenza Sentinel Surveillance System.
J Infect Dis 2009–2010, 206(Suppl 1):S121–135.
doi:10.1186/1471-2458-14-981
Cite this article as: Maman et al.: Implementation of Influenza-like illness
Sentinel Surveillance in Togo. BMC Public Health 2014 14:981.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
